AU1881683A - Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same - Google Patents

Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same

Info

Publication number
AU1881683A
AU1881683A AU18816/83A AU1881683A AU1881683A AU 1881683 A AU1881683 A AU 1881683A AU 18816/83 A AU18816/83 A AU 18816/83A AU 1881683 A AU1881683 A AU 1881683A AU 1881683 A AU1881683 A AU 1881683A
Authority
AU
Australia
Prior art keywords
caffeine
methods
same
inflammatory compositions
improved analgesic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU18816/83A
Other versions
AU558485B2 (en
Inventor
Eugene M. Laska
Carole E. Siegel
Abraham Sunshine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of AU1881683A publication Critical patent/AU1881683A/en
Application granted granted Critical
Publication of AU558485B2 publication Critical patent/AU558485B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AU18816/83A 1982-07-22 1983-07-21 Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same Expired AU558485B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40059782A 1982-07-22 1982-07-22
US400597 1982-07-22

Publications (2)

Publication Number Publication Date
AU1881683A true AU1881683A (en) 1984-02-23
AU558485B2 AU558485B2 (en) 1987-01-29

Family

ID=23584242

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18816/83A Expired AU558485B2 (en) 1982-07-22 1983-07-21 Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same

Country Status (15)

Country Link
JP (3) JPS59501460A (en)
AT (2) AT389226B (en)
AU (1) AU558485B2 (en)
BE (1) BE897356A (en)
CA (1) CA1217429A (en)
CH (1) CH659391A5 (en)
DE (1) DE3390116C2 (en)
FR (1) FR2530469A1 (en)
GB (1) GB2134786B (en)
IE (1) IE55367B1 (en)
IT (1) IT1206502B (en)
NL (1) NL191432C (en)
SE (1) SE466481B (en)
WO (1) WO1984000488A1 (en)
ZA (2) ZA835324B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559343A (en) * 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
CH664085A5 (en) * 1985-02-08 1988-02-15 Ciba Geigy Ag PHARMACEUTICAL PREPARATIONS WITH ANALGETIC EFFECTIVENESS AND THEIR PRODUCTION.
CH669523A5 (en) * 1986-06-25 1989-03-31 Mepha Ag
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
KR20030034171A (en) 2001-07-06 2003-05-01 엔도 파마슈티걸즈, 인크. Oxymorphone controlled release formulations
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US7914831B2 (en) * 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
JP2006282644A (en) * 2005-04-05 2006-10-19 Idemitsu Kosan Co Ltd Fatigue recovery agent
TW201247195A (en) * 2011-04-28 2012-12-01 Kowa Co Stable pharmaceutical composition
JP2018076305A (en) * 2016-10-31 2018-05-17 エスエス製薬株式会社 Pharmaceutical composition
JP6811453B1 (en) * 2020-06-24 2021-01-13 医療法人すぎやま内科 Composition for transdermal absorption

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439094A (en) * 1967-07-20 1969-04-15 Warner Lambert Pharmaceutical Analgesic compositions containing namol xenyrate,caffeine and acetyl-rho-aminophenol
US4049803A (en) * 1976-04-26 1977-09-20 Bristol-Myers Company Augmentation of blood levels of aspirin
JPS5423132A (en) * 1977-07-19 1979-02-21 Dai Ichi Seiyaku Co Ltd Analgesic composition
JPS54154416A (en) * 1978-05-26 1979-12-05 Tdk Electronics Co Ltd High dielectric constant porcelain composition
US4234601A (en) * 1978-12-18 1980-11-18 Mcneilab, Inc. Analgesic potentiation
US4233314A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233315A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233317A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233316A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4237140A (en) * 1979-05-18 1980-12-02 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and acetaminophen
US4315936A (en) * 1979-12-17 1982-02-16 Ortho Pharmaceutical Corporation Analgesic composition
JPS56154416A (en) * 1980-04-30 1981-11-30 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same

Also Published As

Publication number Publication date
AT389998B (en) 1990-02-26
DE3390116T1 (en) 1985-01-10
WO1984000488A1 (en) 1984-02-16
SE8401538L (en) 1984-03-20
NL8320240A (en) 1984-06-01
GB8406704D0 (en) 1984-04-18
AT389226B (en) 1989-11-10
IE831715L (en) 1984-01-22
CA1217429A (en) 1987-02-03
DE3390116C2 (en) 1994-06-16
SE466481B (en) 1992-02-24
JPS59501459A (en) 1984-08-16
GB2134786A (en) 1984-08-22
JPH07165583A (en) 1995-06-27
ZA835326B (en) 1984-09-26
AU558485B2 (en) 1987-01-29
BE897356A (en) 1983-11-14
FR2530469A1 (en) 1984-01-27
SE8401538D0 (en) 1984-03-20
IT8322173A0 (en) 1983-07-21
IT1206502B (en) 1989-04-27
NL191432B (en) 1995-03-01
CH659391A5 (en) 1987-01-30
GB2134786B (en) 1986-05-08
ZA835324B (en) 1984-09-26
NL191432C (en) 1995-07-04
JPS59501460A (en) 1984-08-16
ATA903983A (en) 1989-04-15
ATA245988A (en) 1989-08-15
IE55367B1 (en) 1990-08-29

Similar Documents

Publication Publication Date Title
AU3747485A (en) Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
GB2162747B (en) Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
ZA849680B (en) Analgesic and anti-inflammatory compositions comprising xanthine and methods of using same
AU547389B2 (en) Compositions of dextromethorphan and method
AU529764B2 (en) Analgesic mixture of nalbuphine and acetaminophen
AU560092B2 (en) Improved analgesic and anti-inflammatory compositions comprising ibuprofen and method of using same
AU585662B2 (en) Settable compositions and methods of use thereof
AU558485B2 (en) Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
AU8258282A (en) Analgesic compositions and methods of use
AU2199283A (en) Pharmaceutical compositions of m-chloro-alpha-t- butylaminopropiophenone
AU579405B2 (en) Set delayed cement compositions and methods of using the same
AU559161B2 (en) Compositions of anagrelide and non-steroidal anti- inflammatories
PH17898A (en) Analgesic mixture of nalsuphine and isuprofen
AU565915B2 (en) Pharmaceutical composition of antibiotic and anti- androgen
PH19352A (en) Fluoromethylthiooxacephalosporins derivatives compositions containing same and method of use thereof
AU573524B2 (en) (n-substituted-piperazinyl) derivatives of imidazo- pyridines and pyrido-pyrazines
PT79858B (en) Process for the preparation of azolyl-aryl-alcanol and pharmaceutical compositions therewith
AU576739B2 (en) 2-piperazinyl-or-homo-piperazinyl-quinazoline derivatives and pharmaceutical compositions
PH17118A (en) Antihypertensive pharmaceutical compositions and its method of use
AU6765281A (en) Medicinal compositions and method of use thereof
AU583539B2 (en) Pharmaceutical compositions of L-cysteine and propylene phenoxytol
AU557966B2 (en) Compositions of dextromethorphan
AU557531B2 (en) Composition of analgesic and carbohydrate
NZ211440A (en) Dopamine-beta-hydroxylase inhibitors and pharmaceutical compositions

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired